The store will not work correctly when cookies are disabled.
3-(3,5-difluorophenyl)-2-(4-(methylsulfonyl)phenyl)-1-oxaspiro[4.4]non-2-en-4-one
ID: ALA3986333
PubChem CID: 18385985
Max Phase: Preclinical
Molecular Formula: C21H18F2O4S
Molecular Weight: 404.43
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: CS(=O)(=O)c1ccc(C2=C(c3cc(F)cc(F)c3)C(=O)C3(CCCC3)O2)cc1
Standard InChI: InChI=1S/C21H18F2O4S/c1-28(25,26)17-6-4-13(5-7-17)19-18(14-10-15(22)12-16(23)11-14)20(24)21(27-19)8-2-3-9-21/h4-7,10-12H,2-3,8-9H2,1H3
Standard InChI Key: RSGRKGMCRNCVJN-UHFFFAOYSA-N
Molfile:
RDKit 2D
28 31 0 0 0 0 0 0 0 0999 V2000
24.0659 -13.9624 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.8831 -13.9624 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.1374 -13.1857 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.4745 -12.7036 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.8157 -13.1857 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.1643 -7.9998 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
22.1261 -8.8199 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
22.8554 -8.4429 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
23.8138 -12.2280 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
25.1373 -12.2218 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.8798 -11.4435 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.0635 -11.4512 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.9152 -12.4721 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
23.5803 -10.7941 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.9096 -10.0450 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.4259 -9.3873 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.6128 -9.4775 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.2858 -10.2310 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.7716 -10.8855 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.3522 -10.7817 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.1665 -10.8626 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.6418 -10.1987 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.3040 -9.4537 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.4862 -9.3765 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.0145 -10.0412 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.3154 -8.9116 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.4551 -10.2786 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
25.1457 -8.6336 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 1 0
4 5 1 0
5 1 1 0
7 6 2 0
8 7 2 0
9 4 1 0
4 10 1 0
10 11 1 0
11 12 2 0
12 9 1 0
10 13 2 0
14 15 2 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 14 1 0
12 14 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 24 1 0
24 25 2 0
25 20 1 0
11 20 1 0
17 7 1 0
7 26 1 0
22 27 1 0
24 28 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 404.43 | Molecular Weight (Monoisotopic): 404.0894 | AlogP: 4.15 | #Rotatable Bonds: 3 |
Polar Surface Area: 60.44 | Molecular Species: NEUTRAL | HBA: 4 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: ┄ | CX LogP: 3.90 | CX LogD: 3.90 |
Aromatic Rings: 2 | Heavy Atoms: 28 | QED Weighted: 0.77 | Np Likeness Score: -0.38 |
References
1. (2002) 4,5-diaryl-3(2H)-furanone derivatives as cyclooxygenase-2 inhibitors, |